Central Administration of Drug Control

• Review of product specifications and assessment of the appropriateness of analytical methods and validations, in the quality control part of product dossiers of locally manufactured and imported medical products, raw materials, cosmetics, insecticides, pesticides, medical devices, and diagnostic kits, for marketing authorizations, post-approval variations, and re-registration purposes.
• Performance of compliance testing, including physical, chemical, and microbiological laboratory tests for medical products, raw materials, cosmetics, insecticides, pesticides, medical devices, and diagnostic kits, in the context of market authorization, post-approval variations, re-registration, post market surveillance, as well as in response to complaints and adverse events reported through pharmaceutical vigilance, or in contribution to the detection of suspect falsified and substandard products on the market . 
• Application of risk-based approaches to the selection of tests according to the product's risk, and the criticality of the selected test weighed against its impact on the availability of urgently needed products on the market.
• Issue of reports of compliance/non-compliance of samples to product specifications for samples tested in CADC laboratories in the context of registration, re-registration and post approval variation, as well as post-approval market control
• Development of innovative practices for regulatory oversight through the implementation of advanced projects, aligned with the latest international standards, to improve the efficiency of professionals in the Egyptian pharmaceutical sector, and optimize the use of resources, as well as granting certification and providing services that facilitate the and the acquisition of international accreditations.